GB201403630D0 - Treatment of cystic fibrosis with alginate oligomers - Google Patents

Treatment of cystic fibrosis with alginate oligomers

Info

Publication number
GB201403630D0
GB201403630D0 GB201403630A GB201403630A GB201403630D0 GB 201403630 D0 GB201403630 D0 GB 201403630D0 GB 201403630 A GB201403630 A GB 201403630A GB 201403630 A GB201403630 A GB 201403630A GB 201403630 D0 GB201403630 D0 GB 201403630D0
Authority
GB
United Kingdom
Prior art keywords
treatment
cystic fibrosis
alginate oligomers
oligomers
alginate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201403630A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Algipharma AS
Original Assignee
Algipharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Algipharma AS filed Critical Algipharma AS
Priority to GB201403630A priority Critical patent/GB201403630D0/en
Publication of GB201403630D0 publication Critical patent/GB201403630D0/en
Priority to AU2015222051A priority patent/AU2015222051A1/en
Priority to CN201580010273.7A priority patent/CN106029079A/en
Priority to US15/121,671 priority patent/US20160361342A1/en
Priority to JP2016554405A priority patent/JP2017510563A/en
Priority to KR1020167026840A priority patent/KR20160119259A/en
Priority to CA2940560A priority patent/CA2940560A1/en
Priority to RU2016136449A priority patent/RU2016136449A/en
Priority to EP15708474.0A priority patent/EP3110426A1/en
Priority to PCT/EP2015/054207 priority patent/WO2015128495A1/en
Ceased legal-status Critical Current

Links

GB201403630A 2014-02-28 2014-02-28 Treatment of cystic fibrosis with alginate oligomers Ceased GB201403630D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GB201403630A GB201403630D0 (en) 2014-02-28 2014-02-28 Treatment of cystic fibrosis with alginate oligomers
PCT/EP2015/054207 WO2015128495A1 (en) 2014-02-28 2015-02-27 Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function
JP2016554405A JP2017510563A (en) 2014-02-28 2015-02-27 Use of alginate oligomers in the treatment of cystic fibrosis and other pathologies associated with defective CFTR ion channel function
CN201580010273.7A CN106029079A (en) 2014-02-28 2015-02-27 Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function
US15/121,671 US20160361342A1 (en) 2014-02-28 2015-02-27 Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function
AU2015222051A AU2015222051A1 (en) 2014-02-28 2015-02-27 Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective CFTR ion channel function
KR1020167026840A KR20160119259A (en) 2014-02-28 2015-02-27 Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function
CA2940560A CA2940560A1 (en) 2014-02-28 2015-02-27 Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function
RU2016136449A RU2016136449A (en) 2014-02-28 2015-02-27 APPLICATION OF ALGINATE OLIGOMETES IN THE TREATMENT OF MUKOVISCIDOSIS AND OTHER CONDITIONS ASSOCIATED WITH THE DISTURBED FUNCTION OF CFTR ION CHANNELS
EP15708474.0A EP3110426A1 (en) 2014-02-28 2015-02-27 Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201403630A GB201403630D0 (en) 2014-02-28 2014-02-28 Treatment of cystic fibrosis with alginate oligomers

Publications (1)

Publication Number Publication Date
GB201403630D0 true GB201403630D0 (en) 2014-04-16

Family

ID=50490631

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201403630A Ceased GB201403630D0 (en) 2014-02-28 2014-02-28 Treatment of cystic fibrosis with alginate oligomers

Country Status (1)

Country Link
GB (1) GB201403630D0 (en)

Similar Documents

Publication Publication Date Title
HRP20181692T1 (en) Treatment of fibrosis
IL272032A (en) Methods of treatment for cystic fibrosis
IL271181A (en) Methods of treatment for cystic fibrosis
HK1232147A1 (en) Cenicriviroc for the treatment of fibrosis
HK1258396A1 (en) Cenicriviroc combination therapy for the treatment of fibrosis
IL252839A0 (en) Treatment of pemphigus
IL250960A0 (en) Cenicriviroc combination therapy for the treatment of fibrosis
EP3204007C0 (en) Triazolopyridine compounds and methods for the treatment of cystic fibrosis
EP2968285A4 (en) Compounds and methods for the treatment of cystic fibrosis
SG11201506309SA (en) Eye massager
HK1251166A1 (en) Targeted treatment of leiomyosarcoma
HK1205924A1 (en) Eye massager
GB201416832D0 (en) Methods of treatment
HK1244692A1 (en) Methods of treating fibrosis
HK1247558A1 (en) Cenicriviroc for the treatment of fibrosis
HK1249866A1 (en) Methods of treatment with taselisib
IL251350A0 (en) Treatment of rett syndrome
GB201412010D0 (en) Treatment of hypertransaminasemia
GB201403630D0 (en) Treatment of cystic fibrosis with alginate oligomers
GB201721718D0 (en) Treatment of cystic fibrosis
HK1246718A1 (en) Compounds for treatment of cystic fibrosis
GB201407806D0 (en) Treatment of fibrosis
AU2014904206A0 (en) Treatment of fibrosis
GB201409159D0 (en) Prediction and treatment of progressive fibrosis
GB201311713D0 (en) Cystic fibrosis treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)